Porphyromonas gingivalis with collagen immunization induces ACPA-positive rheumatoid arthritis in C3H mice.

Anti-citrullinated protein antibodies C3H mice Collagen-induced arthritis Porphyromonas gingivalis Rheumatoid arthritis

Journal

Clinical immunology (Orlando, Fla.)
ISSN: 1521-7035
Titre abrégé: Clin Immunol
Pays: United States
ID NLM: 100883537

Informations de publication

Date de publication:
06 Dec 2023
Historique:
received: 21 08 2023
revised: 06 11 2023
accepted: 29 11 2023
medline: 9 12 2023
pubmed: 9 12 2023
entrez: 8 12 2023
Statut: aheadofprint

Résumé

The pathogenic anti-citrullinated protein antibodies (ACPA) are thought to play a vital role in the initiation and immune maintenance of rheumatoid arthritis (RA). However, it is noteworthy that ACPA is not a salient characteristic of any conventional RA animal model. Porphyromonas gingivalis (Pg) was the first microorganism identified to induce citrullination and is a target of autoantibodies in early rheumatoid arthritis (RA). Thus, we employed C3H mice with specific MHC types and combined Pg infection with collagen immunity to develop an animal model of ACPA-positive RA. The resulting model exhibited citrullination characteristics, as well as pathological and immune cell changes. 1) Mice showed a significant increase in ACPA levels, and various organs and tissues exhibited elevated levels of citrullinated protein. 2) The mice experienced heightened pain, inflammation, and bone destruction. 3) The spleen and lymph nodes of the mice showed a significant increase in the proportion of Tfh-GCB cell subpopulations responsible for regulating autoantibody production. In conclusion, the C3H mouse model of Pg infection with collagen immunity demonstrated significant alterations in ACPA levels, citrullinated protein expression, and immune cell subpopulations, which could be a crucial factor leading to increased pain, inflammation, and bone destruction.

Identifiants

pubmed: 38065368
pii: S1521-6616(23)00623-X
doi: 10.1016/j.clim.2023.109859
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

109859

Informations de copyright

Copyright © 2023. Published by Elsevier Inc.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that there is no conflict of interests regarding the publication of this paper.

Auteurs

Chao Yang (C)

Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing, China.

Zhixing Hu (Z)

Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing, China.

Lili Wang (L)

Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing, China.

Luochangting Fang (L)

Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing, China.

Xiaoxiao Wang (X)

Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing, China.

Qun Li (Q)

Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing, China.

Liting Xu (L)

Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing, China.

Jialin Wang (J)

Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing, China.

Chunfang Liu (C)

Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing, China. Electronic address: cfliu@icmm.ac.cn.

Na Lin (N)

Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing, China. Electronic address: nlin@icmm.ac.cn.

Classifications MeSH